跳至主要内容
临床试验/NCT05328856
NCT05328856招募中不适用

An Randomised Controlled Trial on the Effects of Vital Shower (Hansgrohe) on Quality of Life, Immune Function, Cardiovascular Regulation and Well-being

Charite University, Berlin, Germany2 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2022年5月25日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
50
试验地点
2
主要终点
Hospital Anxiety and Depression Scale (HADS-D)

研究概览

简要总结

The aim of this exploratory randomized controlled clinical study is to evaluate the health-promoting effects of Kneipp hydrotherapy, in the form of the Vital Shower in a four-week daily application.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
None

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Female and male patients between 18 and 70 years of age

排除标准

  • Bad general condition
  • Serious acute or chronic comorbidity
  • Pregnancy and breast feeding period/ in the next 6 months
  • Participation in a clinical trial within the last 3 months before enrollment
  • Simultaneous participation in another clinical trial
  • Raynaud's disease or cold agglutinin disease
  • Severe mental illness
  • Insufficiently treated dermatological diseases (e.g. neurodermatitis, psoriasis)
  • Non-compatible sanitary shower or bath devices

结局指标

主要结局

Hospital Anxiety and Depression Scale (HADS-D)

时间窗: Change from HADS-D Baseline, after 4 weeks and 12 weeks

Change

Self-Efficacy Scale (ASKU)

时间窗: Change from ASKU Baseline, after 4 weeks and 12 weeks

Change

Blood pressure at rest (systolic and diastolic)

时间窗: Change from Baseline and after 4 weeks

Flourishing Scale (FS-D)

时间窗: Change from FS-D Baseline, after 4 weeks and 12 weeks

Change

Insomnia Severity Index (ISI-D)

时间窗: Change from ISI-D Baseline, after 4 weeks and 12 weeks

Change

Short Form (SF-36)

时间窗: Change from SF-36 Baseline, after 4 weeks and 12 weeks

Change

Immunological laboratory

时间窗: Change from Baseline and after 4 weeks

T-Cells (CD3), B-Cells (CD19), Natural Killer Cells (CD16), T-helper cells (CD4), cytotoxic T-cells (CD8), CD4/CD8 ratio, interleukin 4, interferon gamma

Von Zerssen somatic complaint list (B-LR and B-LR')

时间窗: Change from B-LR and B-LR' Baseline, after 4 weeks and 12 weeks

Change

WHO-Five Well-Being Index (WHO-5)

时间窗: Change from WHO-5 Baseline, after 4 weeks and 12 weeks

Change

Perceived Stress Scale (PSS-10)

时间窗: Change from PSS-10 Baseline, after 4 weeks and 12 weeks

Change

Heart rate variability

时间窗: Change from Baseline and after 4 weeks

Change

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Andreas Michalsen

Prof. Dr. Andreas Michalsen

Charite University, Berlin, Germany

研究点 (2)

Loading locations...

相似试验